Investor Relations

Company Overview

Ra Medical Systems’ advanced excimer laser systems are tools for use in the treatment of vascular diseases. We believe our products enhance patients’ quality of life by restoring blood-flow in arteries.

DABRA is our minimally-invasive excimer laser and disposable catheter system that is used by physicians as a tool in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease, a form of peripheral artery disease, or PAD, both above- and below-the-knee.  DABRA breaks down plaque to its fundamental chemistry, such as proteins, lipids and other chemical compounds, eliminating blockages by essentially dissolving them without generating potentially harmful particulates. Unlike many treatments for PAD that may damage the arterial wall, DABRA quickly, photochemically dissolves plaque with minimal vascular trauma.

DABRA has been cleared by the FDA for crossing chronic total occlusions in patients with symptomatic infrainguinal lower extremity vascular disease and has an intended use for ablating a channel in occlusive peripheral vascular disease. In addition, DABRA was granted CE mark clearance in September 2016 for the endovascular treatment of infrainguinal arteries via atherectomy and for crossing total occlusions.

Corporate Presentation

Corporate Presentation

Download Corporate Presentation

Latest Annual Filing

Fiscal Year Ended Dec 31, 2020

View Filing

Stock Information

Leadership

Having accumulated decades of collective experience across a variety of fields, our leadership team is the source of our success.

Investor Contact Information

Company

Ra Medical Systems, Inc.
2070 Las Palmas Drive
Carlsbad, CA 92011

Investor Relations

LHA Investor Relations
Jody Cain
Jcain@lhai.com
T: (310) 691-7100